Martin Reese | Enabling precision medicine through genomic interpretation

Monday, November 9, 2015

6:00 pm

Li Ka Shing Center, LK130, 291 Campus Drive, Stanford, CA

Sponsored by:
SPADA: The Stanford Predictives and Diagnostics Accelerator Spectrum | Stanford Center for Clinical & Translational Research & Education

Martin Reese, PhD

Co-founder, President and CSO of Omicia,
a leading provider of genomic analysis software.

Russ Altman, MD, PhD, professor of bioengineering, medicine and genetics, will host a lively discussion with entrepreneur Martin Reese on the potential of genomic interpretation in the clinic.

Martin Reese has been a pioneer in bioinformatics and genomics for over 20 years. His research has contributed to various standards and large scale projects in genomics, including the UCSC genome browser, the Drosophila and Human Genome Projects, genome annotation resulting in the Gene Ontology, and the EGASP int’l gene assessment project.

More recently, Martin has contributed to next generation sequencing-based Precision Medicine projects such as initial NGS sequencing using SOLiD, the GVF genome variant format, VAAST, the first probabilistic disease gene finder for personal genomes, and automatic clinical whole genome interpretation at scale using phenotype integration (PHEVOR) for the 100,000 Genomes Project in the UK and large US-based reference laboratories such as LabCorp. 

Prior to Omicia, he served as VP of discovery informatics at ValiGen, and he co-founded Neomorphic, whose human genome annotation software provided the foundation for Affymetrix microarrays.

When:
Monday, November 9, 2015.
6:00 pm – 7:30 pm
Contact:
650-498-6498, linda.walker@stanford.edu